Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 88-102 , March 2009

Opportunistic Infection and Nuclear Medicine

  • Michael J. O'Doherty, MBBS, FRCP, FRCR, MSc, MD

      Affiliations

    • King's College London, Division of Imaging, St Thomas' Hospital, London, United Kingdom
    • Guy's and St Thomas' Foundation NHS Trust, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Michael J. O'Doherty, MBBS, FRCP, FRCR, MSc, MD, King's College London, Division of Imaging, St Thomas' Hospital, London SE1 7EH, United Kingdom
    • ,
  • Sally F. Barrington, MBBS, FRCP, MSc, MD

      Affiliations

    • King's College London, Division of Imaging, St Thomas' Hospital, London, United Kingdom
    • Guy's and St Thomas' Foundation NHS Trust, London, United Kingdom
    • ,
  • John L. Klein, MB BChir, BA, MSc, MRCP, FRCPath, DTM&H

      Affiliations

    • Guy's and St Thomas' Foundation NHS Trust, London, United Kingdom

References 

  1. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5:361–373
  2. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385–389
  3. Stelljes M, Hermann S, Albring J, et al. Clinical molecular imaging in intestinal graft-versus-host disease: Mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood. 2008;111:2909–2918
  4. Goldenberg DM, Sharkey RM, Udem S, et al. Immumoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients. J Nucl Med. 1994;29:1028–1034
  5. Vinjamuri S, Hall AV, Solanki KK, et al. Comparison of 99mTc infection imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233–235
  6. Lupetti A, Welling MM, Mazzi U, et al. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging. 2002;29:674–679
  7. Gamelli RL, Liu H, He LK, et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–647
  8. Gamelli RL, Liu H, He LK, et al. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock. 1994;1:395–400
  9. Sugawara Y, Gutowski TD, Fisher SJ, et al. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med. 1999;26:333–341
  10. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43:658–663
  11. Hansson L, Ohlsson T, Valind S, et al. Glucose utilisation in the lungs of septic rats. Eur J Nucl Med. 1999;26:1340–13414
  12. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B. 1992;19:183–190
  13. Forstrom LA, Mullan BP, Hung JC, et al. 18F-FDG labelling of human leukocytes. Nucl Med Commun. 2000;21:691–694
  14. Dumarey N, Egrise D, Blocklet D, et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47:625–632
  15. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998;28:352–358
  16. Gorospe L, Raman S, Echeveste J, et al. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26:671–687
  17. Seshadri N, Kaur B, Balan K. Disseminated cryptococcosis: Detection by F-18 FDG PET. Clin Nucl Med. 2007;32:476–478
  18. Castellucci P, Nanni C, Farsad M, et al. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: Prevalence and scan interpretation. Nucl Med Commun. 2005;26:689–694
  19. Mackie GC. F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia. Clin Nucl Med. 2004;29:569–571
  20. Nihashi T, Ito K, Kato T, et al. An abnormal accumulation of fluorine-18-FDG PET in cytomegalovirus enteritis—a case report. Ann Nucl Med. 2006;20:75–78
  21. Chamilos G, Macapinlac HA, Kontoyiannis DP. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol. 2008;46:23–29
  22. Nguyen BD. F-18 FDG PET/CT imaging of disseminated coccidioidomycosis. Clin Nucl Med. 2006;31:568–571
  23. Vahid B, Wildemore B, Nguyen C, et al. Pulmonary blastomycosis masquerading as metastatic disease in the lung: A case report. Med Gen Med. 2006;8:31
  24. Azizirad O, Clifford DB, Groger RK, et al. Histoplasmoma: isolated central nervous system infection with Histoplasma capsulatum in a patient with AIDS (Case report and brief review of the literature). Clin Neurol Neurosurg. 2007;109:176–181
  25. Wilkinson MD, Fulham MJ, McCaughan BC, et al. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med. 2003;28:234–235
  26. Franzius C, Biermann M, Hülskamp G, et al. Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med. 2001;26:232–233
  27. Ho AY, Pagliuca A, Maisey MN, et al. Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol. 1998;101:392–393
  28. Umeoka S, Koyama T, Saga T, et al. High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol. 2005;15:2483–2486
  29. Salhab KF, Baram D, Bilfinger TV. Growing PET positive nodule in a patient with histoplasmosis: case report. J Cardiothorac Surg. 2006;1:23
  30. Sojan SM, Chew G. Pneumocystis carinii pneumonia on F-18 FDG PET. Clin Nucl Med. 2005;30:763–764
  31. Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med. 2005;30:690–691
  32. Hara T, Kosaka N, Suzuki T, et al. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: A positron emission tomography study. Chest. 2003;124:893–901
  33. Lin KH, Wang JH, Peng NJ. Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan. Clin Nucl Med. 2008;33:276–277
  34. Zhuang H, Duarte PS, Rebenstock A, et al. Pulmonary clostridium perfringens infection detected by FDG positron emission tomography. Clin Nucl Med. 2003;28:517–518
  35. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412–1417
  36. Ingui CJ, Shah NP, Oates ME. Infection scintigraphy: Added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis. J Comput Assist Tomogr. 2007;31:375–380
  37. Bar-Shalom R, Yefremov N, Guralnik L, et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587–594
  38. O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus positive patient. J Nucl Med. 1997;38:1575–1583
  39. Kang K, Lim I, Roh JK. Positron emission tomographic findings in a tuberculous brain abscess. Ann Nucl Med. 2007;21:303–306
  40. Mascarenhas NB, Lam D, Lynch GR, et al. PET imaging of cerebral and pulmonary Nocardia infection. Clin Nucl Med. 2006;31:131–133
  41. Rottenberg DA, Sidtis JJ, Strother SC, et al. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med. 1996;37:1133–1141
  42. Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: Report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci. 1995;7:180–187
  43. van Gorp WG, Mandelkern MA, Gee M, et al. Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci. 1992;4:280–287
  44. von Giesen HJ, Antke C, Hefter H, et al. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: Electrophysiologic and positron emission tomography findings. Arch Neurol. 2000;57:1601–1607
  45. Pohl P, Riccabona G, Hilty E, et al. Double-tracer SPECT in patients with AIDS encephalopathy: A comparison of 123I-IMP with 99Tcm-HMPAO. Nucl Med Commun. 1992;13:586–592
  46. Lee VW, Antonacci V, Tilak S, et al. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology. 1999;211:507–512
  47. Antinori A, De Rossi G, Ammassari A, et al. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol. 1999;17:554–560
  48. Lorberboym M, Wallach F, Estok L, et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med. 1998;39:1366–1369
  49. Evaluation and management of intracranial mass lesions in AIDS (Report of the Quality Standards Subcommittee of the American Academy of Neurology). Neurology. 1998;50:21–26
  50. Palestro CJ, Love C, Miller TT. Diagnostic imaging tests and microbial infections. Cell Microbiol. 2007;9:2323–2333
  51. Gemmel F, Dumarey N, Palestro CJ. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging. 2006;33:1226–1237
  52. Sharko AM, Perlman SB, Hinds PW, et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Nat Acad Sci USA. 1996;93:6425–6430
  53. Wallace M, Pyzalski R, Horejsh D, et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute SHIV89,6PD infection in rhesus macaques. Virology. 2000;274:255–261
  54. Scharko AM, Perlman SB, Pyzalski RW, et al. Whole body positron emission tomography in patients with HIV-1 infection. Lancet. 2003;362:959–961
  55. Brust D, Polis M, Davey R, et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: Impact of disease stage and therapy on pattern of nodal activation. Aids. 2006;20:985–993
  56. O'Doherty MJ, Page CJ, Bradbeer CS, et al. The place of lung 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV infection. Respir Med. 1989;83:395–401
  57. O'Doherty MJ, Page CJ, Bradbeer CS, et al. Alveolar permeability in HIV patients with Pneumocystis carinii pneumonia. Genitourin Med. 1987;63:268–270
  58. O'Doherty MJ. 99mTc DTPA transfer/permeability in patients with HIV disease. Q J Nucl Med. 1995;39:231–242
  59. Rosso J, Guillon JM, Parrot A, et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med. 1992;33:81–87
  60. Kramer EL, Sanger JJ, Garay SM, et al. Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med. 1987;28:1107–1114
  61. Tuazon CV, Delaney MD, Simon GL, et al. Utility of gallium-67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis. 1985;132:1087–1092
  62. Lee VW, Fuller JD, O'Brien MJ, et al. Pulmonary Kaposi sarcoma in patients with AIDS: Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology. 1991;180:409–412
  63. Alavi A, Gupta N, Alberini JL, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002;32:293–321

PII: S0001-2998(08)00120-7

doi: 10.1053/j.semnuclmed.2008.10.003

Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 88-102 , March 2009

Article Tools

* Image Usage & Resolution